South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...

FRIDAY, July 11, 2025 (HealthDay News) — Global deaths from AIDS have dropped to their lowest levels in more than 30 years, ...

The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a ...

Just a week before clinical trials were set to begin, South African scientists working on a promising HIV vaccine were told to halt all work, as the Trump administration abruptly withdrew $46 million ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...

Senate Republicans remain wary of eliminating the popular and successful global HIV/AIDS program PEPFAR, as they face down a ...

Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

In the brightly lit corridors of a Nigerian hospital, an unspoken fear lingers, not just among patients, but among the very ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

The UN says the withdrawal of US funding for the global HIV fight could lead to more than 4 million AIDS-related deaths and over 6 million additional HIV infections by 2029 if not replaced.